205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.66%
Revenue growth 1.25-1.5x ADI's 5.49%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
6.29%
Gross profit growth under 50% of ADI's 14.49%. Michael Burry would be concerned about a severe competitive disadvantage.
8.23%
EBIT growth 50-75% of ADI's 16.16%. Martin Whitman would suspect suboptimal resource allocation.
8.57%
Operating income growth at 50-75% of ADI's 16.16%. Martin Whitman would doubt the firm’s ability to compete efficiently.
0.46%
Net income growth under 50% of ADI's 14.06%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.72%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.73%
Dividend growth at 50-75% of ADI's 0.98%. Martin Whitman would question if the firm lags in returning cash to shareholders.
-29.07%
Negative OCF growth while ADI is at 31.41%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.10%
Negative FCF growth while ADI is at 34.39%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
53.66%
10Y revenue/share CAGR 1.25-1.5x ADI's 45.41%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
48.77%
5Y revenue/share CAGR above 1.5x ADI's 32.02%. David Dodd would look for consistent product or market expansions fueling outperformance.
17.46%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
133.79%
10Y OCF/share CAGR above 1.5x ADI's 53.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
87.28%
5Y OCF/share CAGR at 50-75% of ADI's 132.49%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
49.88%
3Y OCF/share CAGR above 1.5x ADI's 17.73%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
106.89%
Net income/share CAGR above 1.5x ADI's 53.15% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
120.86%
5Y net income/share CAGR above 1.5x ADI's 42.50%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
49.13%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
15.89%
Below 50% of ADI's 87.15%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.63%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1.63%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
463.52%
Dividend/share CAGR of 463.52% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
378.03%
5Y dividend/share CAGR above 1.5x ADI's 231.40%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
200.44%
3Y dividend/share CAGR above 1.5x ADI's 23.29%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
19.50%
AR growth well above ADI's 4.07%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.16%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.07%
Asset growth well under 50% of ADI's 8.63%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.59%
Under 50% of ADI's 9.34%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
4.52%
R&D growth drastically higher vs. ADI's 3.88%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.16%
SG&A growth well above ADI's 6.15%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.